Vivimed Skin Lightening Formulation Formula Ref. 2-016-32

Vivimed Labs Ltd

Phase

Product

INCI Name

Supplier

Volume

Finsolv EB

Ethylhexyl benzoate

Innospec

8.00

Crodamol AB

C12-15 Alkyl Benzoate

Croda

5.50

OMC

Ethyl Hexyl Methoxycinnamate

Vivimed

4.00

RonaCare AP

Bis-ethylhexyl Hydroxydimethoxy Benzylmalonate

Merck

1.00

Avis

Butyl Methoxydibenzoylmethane

Vivimed

2.00

Ben-3

Benzophenone-3

Vivimed

2.00

Etone

Ethylhexyl Triazone

Vivimed

1.00

Vivinol

4-butylresorcinol

Vivimed

0.10

Titriplex III

Disodium EDTA

Merck

0.10

Vitamin E Acetate

Tocopheryl Acetate

Various

1.00

Deionised Water

Aqua

69.80

Pricerine 9091

Glycerine

Croda

3.00

Polasperse CSI

Carbomer (and) Sorbitan Oleate (and) Parafinnum Liquidum (and) Polysorbate 80 (and) Caprylic/Capric Triglyceride (and) Trideceth-6

Lubrizol

2.00

Nipaguard BPX

Phenoxyethanol (and) Methylparaben (and) Propylparaben (and) 2-Bromo-2-Nitropropane-1,3-Diol

Clariant

0.50

Preparation:

1. Disperse PolaSperse CSI in water with vigorous stirring (anchor stirrer, 300rpm). 2. Increase speed to 500 rpm and stir for 20 minutes. 3. Add glycerine with stirring. 4. Combine oil phase (part A) ingredients, and heat to 50oC. 5. Add oil phase to water phase with stirring. 6. Homogenise for 2 minutes. 7. Add part C with stirring.

Notes:

Test Data: 78400cps / pH7 / in-vitro SPF8 / UVA:UVB ratio 0.785

Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Featured Supplier

Wilshire Technologies, Inc. An Evonik Company

Wilshire Technologies was founded in 1997 and acquired by Evonik in 2020. WTI provides both a select line of value-added cosmetic actives and affordable access to GMP produced materials for the pharmaceutical industry. WTI offers a highly diverse portfolio of value-focused products including a broad range of high-purity phytochemicals...

Learn more »